Glaucoma Trial, Recruiting
Who may be able to join
AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI
Who might be able to join this trial:
- People who have glaucoma where surgery is needed to reduce eye pressure, and who also have a cloudy lens (cataract) where cataract surgery is recommended
- People who are medically suitable to have both eye surgeries performed
- People who are not expected to need any additional eye surgery within the next 12 months
- People who are over 18 years old
Who may not be able to join:
- People who are unwilling or unable to attend follow-up appointments at the clinic
- People whose glaucoma is of a specific type, including angle closure, uveitic, neovascular, or congenital glaucoma, or who have certain eye conditions such as iridocorneal endothelial syndrome or Axenfeld-Rieger syndrome
- People who have previously had certain eye procedures, including glaucoma filtering surgery, a suprachoroidal stent, retinal surgery, corneal graft surgery, or a procedure to reduce eye pressure using laser or cold treatment (cyclophotocoagulation)
- People who have a known allergy to any medications or substances required as part of the trial
- People who are pregnant
Important: Always verify eligibility with the trial site directly before applying.
Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.
Contact this trial
Principal Investigator: Ewald Lindner, Prof., Medical University of Graz
Phone: +4331638580810
Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.
GP referral letter
Print a one-page summary to share with your doctor.
Trial details
Where this trial is recruiting
Primary endpoints
Intraocular Pressure After Surgery
Can't join this trial?
Data last synced from ClinicalTrials.gov: 22 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.